Scholarlink

Background and objective <p>The regulatory framework for the provision and reimbursement of ambulatory hospital services suggests that there is additional potential to shift oncology care from inpatient to outpatient settings. This study examines how many inpatient cancer-related treatment cases in German acute-care hospitals could potentially be delivered on an outpatient basis and identifies the types of services provided in these treatment cases.</p> Materials and methods <p>Nationwide hospital discharge data from the diagnosis-related group (DRG) statistics for the years 2017 to 2023 were analysed. Included were inpatient treatment cases of adults with a&#xa0;primary diagnosis of a&#xa0;malignant or in&#xa0;situ neoplasm. Potentially outpatient-applicable cases were identified using the IGES Institute algorithm and stratified by cancer type and type of care.</p> Results <p>The number of potentially outpatient-applicable treatment cases decreased from 315,530 (21.0% of cancer-related inpatient treatments) in 2017 to 237,566 (16.5%) in 2023. The highest absolute numbers were observed for tumours of the trachea, lung and bronchi (2023: 41,311). With regard to the type of care, the highest numbers were found for cases involving exclusively diagnostic procedures (2023: 95,372) and for minor surgical interventions (2023: 69,381).</p> Conclusion <p>Although the outpatient potential has declined in recent years, a&#xa0;substantial number of cancer-related inpatient treatments remained potentially outpatient-applicable in 2023. Optimising the regulatory conditions for outpatient oncology care may help to shift such treatments increasingly to the outpatient setting, thereby improving care quality, promoting efficient resource use and supporting patient preferences.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ambulantes Potenzial in der onkologischen Versorgung

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月31日

查看全文
  • Carolina Pioch,
  • Reinhard Busse,
  • Philipp Hengel,
  • Rebecca Roth,
  • Manije Sabet-Rashedi,
  • Martin Utzig,
  • Ulrike Nimptsch

摘要

Background and objective

The regulatory framework for the provision and reimbursement of ambulatory hospital services suggests that there is additional potential to shift oncology care from inpatient to outpatient settings. This study examines how many inpatient cancer-related treatment cases in German acute-care hospitals could potentially be delivered on an outpatient basis and identifies the types of services provided in these treatment cases.

Materials and methods

Nationwide hospital discharge data from the diagnosis-related group (DRG) statistics for the years 2017 to 2023 were analysed. Included were inpatient treatment cases of adults with a primary diagnosis of a malignant or in situ neoplasm. Potentially outpatient-applicable cases were identified using the IGES Institute algorithm and stratified by cancer type and type of care.

Results

The number of potentially outpatient-applicable treatment cases decreased from 315,530 (21.0% of cancer-related inpatient treatments) in 2017 to 237,566 (16.5%) in 2023. The highest absolute numbers were observed for tumours of the trachea, lung and bronchi (2023: 41,311). With regard to the type of care, the highest numbers were found for cases involving exclusively diagnostic procedures (2023: 95,372) and for minor surgical interventions (2023: 69,381).

Conclusion

Although the outpatient potential has declined in recent years, a substantial number of cancer-related inpatient treatments remained potentially outpatient-applicable in 2023. Optimising the regulatory conditions for outpatient oncology care may help to shift such treatments increasingly to the outpatient setting, thereby improving care quality, promoting efficient resource use and supporting patient preferences.